StockData

Aibotics, Inc. (AIBT) stock

AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.00+0.00 (+42.86%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Aibotics cash

Cash and short-term investments held at the end of each period.

Aibotics's cash was $233.43K at Jun 30, 2026. For fiscal 2025 it was $255.94K, up 38.3% from the year before. The highest annual figure on record is $1.27M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$255.94K+38.3%
FY2024Dec 31, 2024$185.10K-33.7%
FY2023Dec 31, 2023$279.13K-27.7%
FY2022Dec 31, 2022$385.90K-69.6%
FY2021Dec 31, 2021$1.27M+1044.5%
FY2020Dec 31, 2020$110.75K–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$611.50K-10.1%
FY2017Dec 31, 2017$680.03K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$233.43K-3.6%
Q1 FY2026Mar 31, 2026$288.86K+84.3%
Q4 FY2025Dec 31, 2025$255.94K+38.3%
Q3 FY2025Sep 30, 2025$230.47K+13.9%
Q2 FY2025Jun 30, 2025$242.18K-13.5%
Q1 FY2025Mar 31, 2025$156.74K-57.7%
Q4 FY2024Dec 31, 2024$185.10K-33.7%
Q3 FY2024Sep 30, 2024$202.36K-36.2%
Q2 FY2024Jun 30, 2024$279.91K-17.4%
Q1 FY2024Mar 31, 2024$370.43K+3.8%
Q4 FY2023Dec 31, 2023$279.13K-27.7%
Q3 FY2023Sep 30, 2023$316.99K-27.7%
Q2 FY2023Jun 30, 2023$338.89K-56.7%
Q1 FY2023Mar 31, 2023$357.03K-75.9%
Q4 FY2022Dec 31, 2022$385.90K-69.6%
Q3 FY2022Sep 30, 2022$438.43K-53.7%
Q2 FY2022Jun 30, 2022$783.38K+52.4%
Q1 FY2022Mar 31, 2022$1.48M+1338.7%
Q4 FY2021Dec 31, 2021$1.27M+1044.5%
Q3 FY2021Sep 30, 2021$947.40K+703.3%
Q2 FY2021Jun 30, 2021$513.93K+314.9%
Q1 FY2021Mar 31, 2021$103.05K-17.5%
Q4 FY2020Dec 31, 2020$110.75K–
Q3 FY2020Sep 30, 2020$117.93K-84.4%
Q2 FY2020Jun 30, 2020$123.86K-80.6%
Q1 FY2020Mar 31, 2020$124.97K-79.9%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$754.42K+3.9%
Q2 FY2019Jun 30, 2019$639.72K-8.4%
Q1 FY2019Mar 31, 2019$621.93K-8.5%
Q4 FY2018Dec 31, 2018$611.50K–
Q3 FY2018Sep 30, 2018$725.90K–
Q2 FY2018Jun 30, 2018$698.64K–
Q4 FY2017Dec 31, 2017$680.03K–

More Aibotics figures

See a number that looks wrong?